MedTrace Logo

Study of Eating Patterns with a Smartphone App and the Effects of Time Restricted Feeding in the Metabolic Syndrome

NCT03241121 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 235

Last updated 2024-12-06

No results posted yet for this study

Summary

SwissChronoFood - Study of eating patterns with a smartphone app and the metabolic effects of time restricted feeding in metabolic syndrome

The purpose of this study is to assess eating patterns among teenagers and adults with a new method, going beyond the pen-and-paper food diaries, and to investigate whether time restricted feeding leads to weight loss, improvement in lipid and glucose metabolism in individuals with components of the metabolic syndrome

Conditions

  • Eating Behavior
  • Metabolic Syndrome
  • Obesity
  • Dyslipidemias
  • Glucose Intolerance
  • Steatosis of Liver

Interventions

BEHAVIORAL

Time restricted feeding

To eat only during a self-selected window of 12 hours, with no advice on nutrition quality, quantity or caloric intake

BEHAVIORAL

Regular dietary advices

Regular dietary advices by a trained dietitian or research nurse according to current nutrition guidelines

DEVICE

Eating patterns

Data collection on eating patterns via the smartphone app

Sponsors & Collaborators

  • Salk Institute for Biological Studies

    collaborator OTHER

  • University of Lausanne Hospitals

    lead OTHER

Principal Investigators

  • Tinh-Hai Collet, MD · University of Lausanne Hospitals

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-09-29
Primary Completion
2021-03-31
Completion
2022-03-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03241121 on ClinicalTrials.gov